Hutch News

Hutch News

Stories tagged 'Seattle HIV Vaccine Trials Unit'

Finding a better way to take a bite out of malaria’s power

Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs

Sept. 10, 2014 | By Mary Engel / Fred Hutch News Service

Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs.

View story >


McElrath receives HIV advocacy award

Julie McElrath honored as national recipient of Global Alliance to Immunize against AIDS achievement award

Dec. 6, 2010

In celebration of World AIDS Day on Dec. 1, the Global Alliance to Immunize against AIDS Vaccine Foundation honored the humanitarian work of three noted HIV/AIDS advocates, including Dr. Julie McElrath, co-director of the Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division and a Hutchinson Center senior vice president.

View story >


'Elite controllers’ may carry key to HIV vaccine

Julie McElrath, HIV Vaccine Trials Unit contribute to research breakthrough that may explain how some HIV-positive people control the virus with immune system alone

Nov. 15, 2010 | By Kristen Woodward

An international research consortium involving Dr. Julie McElrath and other clinical researchers from the Seattle HIV Vaccine Trials Unit—a joint program of the Fred Hutchinson Cancer Research Center and the University of Washington—is a significant step closer to understanding the genetics of "elite controllers."

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.